Clinical Trials Directory

Trials / Completed

CompletedNCT01462448

Study to Identify the Genetic Variations Associated With Phantom Limb Pain

Status
Completed
Phase
Study type
Observational
Enrollment
726 (actual)
Sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if there is a genetic component to phantom limb pain. DNA will be analyzed for single nucleotide polymorphisms (SNPs) between the control and phantom limb pain group. Total RNA will also be isolated and profiled to asses the degree to which our gene(s) of interest are expressed in the presence or absence of phantom limb pain. Some proteins, such as inflammatory antibodies or the neurotrophin brain-derived neurotrophic factor (BDNF), will also be assessed for their association(s) with phantom limb pain.

Detailed description

Most patients (90-95%)with major limb amputations experience a phantom limb--the vivid impression that the limb is still present. In many cases, the sensation is painful for reasons that are currently not well understood. A small subset of amputees (\<10%) never experience phantom limb pain (PLP), the painful sensation felt in the amputated limb. This difference suggests that there may be a genetic component that precludes some patients from ever experiencing PLP. Understanding the genetic components of PLP may help in predicting which patients will experience PLP and which amputees will respond to the various treatment options available. In order to understand the genetic aspects and ultimately develop more effective treatment options in the future, patients with and without PLP will be asked to give 30 mls of blood after overnight fasting. These blood samples will be de-identified and sent to the National Institutes of Health (NIH) in Bethesda, Maryland, where all of the genetic analyses will take place.

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood DrawSingle blood draw of 30 ml

Timeline

Start date
2012-03-01
Primary completion
2014-04-01
Completion
2023-08-06
First posted
2011-10-31
Last updated
2025-08-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01462448. Inclusion in this directory is not an endorsement.